# Research timeline and gaps: Sauna and Cardiovascular Prevention

Selected publication milestones, not an exhaustive history or discovery priority claim.

**2003 — Small controlled warm/cold hydrotherapy bundle has selected heart-failure symptom/function effects without isolating modalities.** [Original PMID14564334](https://pubmed.ncbi.nlm.nih.gov/14564334/).

**2004 — Supervised sauna reduces measured ectopy in a small heart-failure trial; hard-event reduction remains a different outcome.** [Original PMID15564698](https://pubmed.ncbi.nlm.nih.gov/15564698/).

**2008 — Multicenter Waon report adds short-term disease-specific cardiac and symptom data, with many within-arm contrasts.** [Original PMID18922381](https://pubmed.ncbi.nlm.nih.gov/18922381/).

**2009 — Small supervised sauna crossover is tolerated but lacks significant between-arm function/QoL efficacy.** [Original PMID19154844](https://pubmed.ncbi.nlm.nih.gov/19154844/).

**2009 — Matched severe-heart-failure Waon follow-up reports a five-year HF/cardiac-death composite association; allocation and primary-prevention scope remain unresolved.** [Original PMID19304125](https://pubmed.ncbi.nlm.nih.gov/19304125/).

**2012 — Acute sauna/exercise hypertension comparisons address short-term hemodynamics.** [Original PMID22863164](https://pubmed.ncbi.nlm.nih.gov/22863164/).

**2015 — Finnish male cohort links baseline sauna frequency/duration with fatal events prospectively.** [Original PMID25705824](https://pubmed.ncbi.nlm.nih.gov/25705824/).

**2015 — Chronic cold recovery attenuates selected strength adaptation despite acute recovery rationale.** [Original PMID26174323](https://pubmed.ncbi.nlm.nih.gov/26174323/).

**2016 — WAON-CHF primaryBNP is null while selected secondary functional measures improve.** [Original PMID27001189](https://pubmed.ncbi.nlm.nih.gov/27001189/).

**2016 — Unblinded cold showers reduce self-reported absence rather than overall illness days.** [Original PMID27631616](https://pubmed.ncbi.nlm.nih.gov/27631616/).

**2018 — KIHD fitness/sauna joint analysis narrows measured confounding without creating independent exposure allocation.** [Original PMID28972808](https://pubmed.ncbi.nlm.nih.gov/28972808/).

**2018 — Older men-and-women Finnish cohort expands observational enrollment and adds fatal-event associations.** [Original PMID30486813](https://pubmed.ncbi.nlm.nih.gov/30486813/).

**2019 — PAD heat-plus-calisthenics versus exercise comparison shows functional improvement without clear between-arm superiority.** [Original PMID31002283](https://pubmed.ncbi.nlm.nih.gov/31002283/).

**2020 — Named home auricular device with active sensory comparator reduces objective AF burden in a defined disease trial.** [Original PMID32192678](https://pubmed.ncbi.nlm.nih.gov/32192678/).

**2022 — Exercise-plus-sauna randomized trial adds BP and estimated-fitness benefits over exercise.** [Original PMID35785965](https://pubmed.ncbi.nlm.nih.gov/35785965/).

**2023 — CAD randomized exposure achieves acclimation without the predicted vascular/BP benefit.** [Original PMID37650138](https://pubmed.ncbi.nlm.nih.gov/37650138/).

**2024 — Defined cervical-stimulation diabetes trial is clinically symptom-null despite broader vagal-treatment hypotheses.** [Original PMID38546822](https://pubmed.ncbi.nlm.nih.gov/38546822/).

**2024 — Specific sham-controlled auricular insomnia trial has clinically meaningful symptom effects.** [Original PMID39680406](https://pubmed.ncbi.nlm.nih.gov/39680406/).

**2025 — Cold/hot athlete recovery does not exceed placebo in measured acute and longer-term performance outcomes.** [Original PMID40498100](https://pubmed.ncbi.nlm.nih.gov/40498100/).

**2025 — Added hot-water exposure improves selected vascular/BP measures beyond exercise but not all cardiometabolic endpoints.** [Original PMID40719540](https://pubmed.ncbi.nlm.nih.gov/40719540/).

**2025 — Hyperacute-stroke device trial changes molecular/autonomic measures without its primaryBP-variability benefit.** [Original PMID41455014](https://pubmed.ncbi.nlm.nih.gov/41455014/).

**2026 — Open HFpEF sauna pilot shows function gains and partial loss after withdrawal, with a controlled trial described as planned.** [Original PMID41831305](https://pubmed.ncbi.nlm.nih.gov/41831305/).

**2026 — Acute CKD controlled sauna pilot shows selected function and vascular positives with limited horizon.** [Original PMID42113470](https://pubmed.ncbi.nlm.nih.gov/42113470/).

## Research gaps

Independent clinical-event causal evidence for habitual sauna, with repeated exposure and settings beyond the Finnish cohort family.

Whether BP/vascular/autonomic changes mediate events rather than simply coexist with exposure.

Sauna-alone versus exercise-plus-sauna and modality equivalence without substituting water immersion, infrared Waon or local heating.

Durable cold-health endpoints and indication-specific recovery/adaptation tradeoffs, with measured expectancy and adherence.

Exact consumer-device identity and indication-specific active-sham evidence; implanted, cervical and auricular stimulation cannot be interchanged by label.

Longer-term benefit-harm data in predefined disease and medication strata without converting supervised short tolerability into universal safety.

## Boundary experiment

A multicenter randomized pragmatic sauna-plus-usual-care versus matched usual-care/time-contact study, or a validated independent access/withdrawal natural experiment, with adjudicated cardiovascular hospitalization, infarction, stroke and cardiovascular death over prespecified follow-up, stratifying baseline disease and exercise before outcomes.